288 related articles for article (PubMed ID: 37251686)
1. Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus.
Chen X; Zhang S; Peng X; Shi X; Wu H; Wen Y; Qin Y; Tian X; Zhu H; Chen L
Front Endocrinol (Lausanne); 2023; 14():1173903. PubMed ID: 37251686
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA.
Gong Y; Shen C; Meng T; Lin W; Hu X; Tang R; Xiong Q; Ooi JD; Eggenhuizen PJ; Chen J; Zhou YO; Luo H; Xu J; Liu N; Xiao P; Xiao X; Zhong Y
Clin Exp Med; 2024 Apr; 24(1):66. PubMed ID: 38564029
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
Kim SM; Choi SY; Kim SY; Kim J
Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).
Shimojima Y; Kishida D; Ichikawa T; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Hirata S; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Sekijima Y
Arthritis Res Ther; 2022 Aug; 24(1):204. PubMed ID: 35999568
[TBL] [Abstract][Full Text] [Related]
8. Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
Fernandes-Serodio J; Prieto-González S; Espígol-Frigolé G; Ríos-Garcés R; Gómez-Caverzaschi V; Araújo O; Espinosa G; Jordà-Sánchez R; Alba MA; Quintana L; Blasco M; Guillen E; Viñas O; Ruiz-Ortiz E; Pelegrín L; Sainz de la Maza M; Sánchez-Dalmau B; García-Herrera A; Solé M; Castillo P; Aldecoa I; Cano MD; Sellarés J; Hernández-González F; Agustí C; Lucena CM; López-Rueda A; Sánchez M; Benegas M; Capurro S; Sanmartí R; Grau JM; Vilaseca I; Alobid I; Cid MC; Hernández-Rodríguez J
J Intern Med; 2024 May; 295(5):651-667. PubMed ID: 38462959
[TBL] [Abstract][Full Text] [Related]
9. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
[TBL] [Abstract][Full Text] [Related]
10. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
[TBL] [Abstract][Full Text] [Related]
11. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
Holding S; Fisher VJ; Abuzakouk M
Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
[TBL] [Abstract][Full Text] [Related]
12. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.
Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T
Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
Chang DY; Li ZY; Chen M; Zhao MH
Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
[TBL] [Abstract][Full Text] [Related]
15. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538
[TBL] [Abstract][Full Text] [Related]
16. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
Mohammad AJ; Segelmark M
J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.
Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313
[TBL] [Abstract][Full Text] [Related]
18. Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients.
Qi F; Hao J; Wei W
Ann Med; 2023; 55(2):2289614. PubMed ID: 38056010
[TBL] [Abstract][Full Text] [Related]
19. The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
Ono N; Inoue Y; Miyamura T; Ueda N; Nagano S; Inoue H; Oryoji K; Ota SI; Sawabe T; Yoshizawa S; Takeyama Y; Sadanaga Y; Takamori A; Kimoto Y; Miyake K; Horiuchi T; Nakashima H; Niiro H; Tada Y
J Rheumatol; 2021 Mar; 48(3):417-425. PubMed ID: 31523048
[TBL] [Abstract][Full Text] [Related]
20. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
